Stocks
G1 Therapeutics (GTHX) Net margin US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -219.2% | -471.3% | -287.6% | -58.1% | -76.9% | |||
| Changes by years, y/y, % | -252pp | +184pp | +229pp | -35.7% | |||||
G1 Therapeutics. Net margin, %
G1 Therapeutics. Net margin, changes, pp
G1 Therapeutics (GTHX) Net margin US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| Net margin, % | ? | 20.5% | -148.0% | -73.1% | -70.6% | -33.1% | -76.9% | |
| Changes by years, y/y, % | +417pp | -41pp | +255pp | +181pp | -54pp | |||
| Changes by quarters, q/q, % | +272pp | -169pp | +75pp | +3pp | +38pp | |||
